Vaxart, Inc.
NASDAQ: VXRT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Steven Lo
- Employees
- 105
- Headquarters
- South San Francisco, United States
- IPO year
- 1981
- Market cap
- $125.9M
- Website
- https://vaxart.com
Loading VXRT…
Loading profile data…Frequently asked questions about VXRT
What does Vaxart, Inc. (VXRT) do?
Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company leverages its unique proprietary platform for delivering these oral vaccine solutions. Its diverse pipeline showcases several promising candidates:...
Where does VXRT trade?
Vaxart, Inc. (VXRT) trades on the NASDAQ Capital Market.
What sector is VXRT in?
Vaxart, Inc. (VXRT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Vaxart, Inc.?
Steven Lo is the chief executive officer of Vaxart, Inc. (VXRT).
Where is Vaxart, Inc. headquartered?
Vaxart, Inc. is headquartered in United States.
Does VXRT pay a dividend?
Vaxart, Inc. (VXRT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VXRT go public?
Vaxart, Inc. (VXRT) completed its initial public offering in 1981.